IoMT-Enabled Real-time Blood Glucose Prediction with Deep Learning and Edge Computing

Blood glucose (BG) prediction is essential to the success of glycemic control in type 1 diabetes (T1D) management. Empowered by the recent development of the Internet of Medical Things (IoMT), continuous glucose monitoring (CGM) and deep learning technologies have been demonstrated to achieve the state of the art in BG prediction. However, it is challenging to implement such algorithms in actual clinical settings to provide persistent decision support due to the high demand for computational resources, while smartphone-based implementations are limited by short battery life and require users to carry the device. In this work, we propose a new deep learning model using an attention-based evidential recurrent neural network and design an IoMT-enabled wearable device to implement the embedded model, which comprises a low-cost and low-power system on a chip to perform Bluetooth connectivity and edge computing for real-time BG prediction and predictive hypoglycemia detection. In addition, we developed a smartphone app to visualize BG trajectories and predictions, and desktop and cloud platforms to backup data and fine-tune models. The embedded model was evaluated on three clinical datasets including 47 T1D subjects. The proposed model achieved superior performance of root mean square error (RMSE), mean absolute error, and glucose-specific RMSE, and obtained the best accuracy for hypoglycemia detection when compared with a group of machine learning baseline methods. Moreover, we performed hardware-in-the-loop in silico trials with 10 virtual T1D adults to test the whole IoMT system with predictive low-glucose management, which significantly reduced hypoglycemia and improved BG control

Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing

We review some emerging trends in transduction, connectivity and data analytics for Point-of-Care Testing (POCT) of infectious and non-communicable diseases. The patient need for POCT is described along with developments in portable diagnostics, specifically in respect of Lab-on-chip and microfluidic systems. We describe some novel electrochemical and photonic systems and the use of mobile phones in terms of hardware components and device connectivity for POCT. Developments in data analytics that are applicable for POCT are described with an overview of data structures and recent AI/Machine learning trends. The most important methodologies of machine learning, including deep learning methods, are summarised. The potential value of trends within POCT systems for clinical diagnostics within Lower Middle Income Countries (LMICs) and the Least Developed Countries (LDCs) are highlighted

Non-invasive Hyperglycemia Detection using ECG and Deep Learning

Hyperglycemia is characterized by an elevated level of glucose in the blood. It is normally asymptomatic, except for an extremely high level, and thus a person can live in that state for years before the negative - sometimes irreversible - health impacts appear. Unexpected hyperglycemia can also be an indication of diabetes, a chronic disease that, when not treated, can lead to serious consequences, including limb amputations and even death. Therefore, identifying hyperglycemic state is important. The most common and direct way to measure a person’s glucose level is by directly assessing it from a blood sample by pricking a finger, which causes discomfort and even pain. The constant finger pricking can also lead to bruising and increases the possibility of infection. This thesis presents a non-invasive technique of detecting hyperglycemia by using a person’s electrocardiogram (ECG) and deep learning. The ECG signal is preprocessed to remove noise, identify fiducial points, extract and adjust features, remove outliers and normalize the data. This thesis applied a novel approach to feature extraction in which, instead of just using fiducial amplitudes and intervals, a direct line was drawn between fiducial points and its length and slope were used as features. The labeled features were used in 10-layer deep neural network and resulted in an area under the curve (AUC) of 94.53%, sensitivity of 87.57% and specificity of 85.04%. Such strong performance indicates that ECG carry intrinsic information that can be used to identify hyperglycemic state, enabling the use of ECG-based hardware together with deep learning for non-invasive hyperglycemia detection

Development of a neural network model for predicting glucose levels in a surgical critical care setting

Development of neural network models for the prediction of glucose levels in critically ill patients through the application of continuous glucose monitoring may provide enhanced patient outcomes. Here we demonstrate the utilization of a predictive model in real-time bedside monitoring. Such modeling may provide intelligent/directed therapy recommendations, guidance, and ultimately automation, in the near future as a means of providing optimal patient safety and care in the provision of insulin drips to prevent hyperglycemia and hypoglycemia

Wireless body sensor networks for health-monitoring applications

This is an author-created, un-copyedited version of an article accepted for publication in Physiological Measurement. The publisher is not responsible for any errors or omissions in this version of the manuscript or any version derived from it. The Version of Record is available online at http://dx.doi.org/10.1088/0967-3334/29/11/R01

Measures of disease activity in glaucoma

Glaucoma is the leading cause of irreversible blindness globally which significantly affects the quality of life and has a substantial economic impact. Effective detective methods are necessary to identify glaucoma as early as possible. Regular eye examinations are important for detecting the disease early and preventing deterioration of vision and quality of life. Current methods of measuring disease activity are powerful in describing the functional and structural changes in glaucomatous eyes. However, there is still a need for a novel tool to detect glaucoma earlier and more accurately. Tear fluid biomarker analysis and new imaging technology provide novel surrogate endpoints of glaucoma. Artificial intelligence is a post-diagnostic tool that can analyse ophthalmic test results. A detail review of currently used clinical tests in glaucoma include intraocular pressure test, visual field test and optical coherence tomography are presented. The advanced technologies for glaucoma measurement which can identify specific disease characteristics, as well as the mechanism, performance and future perspectives of these devices are highlighted. Applications of AI in diagnosis and prediction in glaucoma are mentioned. With the development in imaging tools, sensor technologies and artificial intelligence, diagnostic evaluation of glaucoma must assess more variables to facilitate earlier diagnosis and management in the future

OCM 2021 - Optical Characterization of Materials : Conference Proceedings

The state of the art in the optical characterization of materials is advancing rapidly. New insights have been gained into the theoretical foundations of this research and exciting developments have been made in practice, driven by new applications and innovative sensor technologies that are constantly evolving. The great success of past conferences proves the necessity of a platform for presentation, discussion and evaluation of the latest research results in this interdisciplinary field